Researchers believe their new findings may supersede the amyloid hypothesis of Alzheimer's disease.
Researchers have identified key molecular pathways which lead to late-onset Alzheimer's disease. The study presents a new approach to Alzheimer's research and highlights several potential drug targets.
Researchers have identified and validated two rare gene mutations which could be a cause for late onset Alzheimer's disease.
Researchers have developed a new rat model of Alzheimer's disease that can be used to study the accumulation of amyloid plaques.
Researchers at UBC believe they have identified a method that could help stop Alzheimer's disease in its tracks.
An international research team revealed the atomic‐level structure of the human peptidase enzyme meprin β (beta).
Researchers identify compounds that stabilize retromer protein complex and protects neurons from amyloid-beta.
Study identifies the main components driving amyloid beta-associated synaptic degeneration.
Researchers identified gene recombination in neurons that produces new gene variants in the brains of those with Alzheimer's disease. The findings, researchers say, may point to a potential near term treatment for the neurodegenerative disease.